Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -2.09 | 30.11 |
| PEG Ratio (TTM) | -0.08 | -0.34 |
| P/S Ratio (TTM) | 0.26 | 3.58 |
| P/B Ratio (TTM) | 1.93 | 32.07 |
| P/FCF Ratio (TTM) | -5.10 | 25.07 |
| Price to 5YR AVG Earnings Ratio | N/A | 26.83 |
| Price to 5YR AVG FCF Ratio | N/A | 24.50 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23.08% | 10.88% |
| ROE (TTM) | -133.58% | 119.88% |
| Net Profit Margin (TTM) | -11.35% | 13.13% |
| ROIC 5YR AVG | N/A | 26.54% |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -10.68% | 48.21% | N/A |
| Revenue | -5.91% | 15.13% | N/A |
| Net Income | -10.60% | 0.88% | N/A |
| Cash Flow | -256.33% | 1.77% | N/A |
Health (35%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.07 | 0.90 |
| Quick Ratio (TTM) | 1.45 | 0.63 |
| D/E Ratio (TTM) | 1.22 | 3.89 |
| Interest Coverage (TTM) | -1.28 | 15.14 |
| Piotroski F-Score | 3 | 8 |
| Altman Z-Score | N/A | 5.32 |
| LTL to 5YR AVG FCF | N/A | 4.27 |
| Shares Outstanding Growth 5YR AVG | N/A | -0.25% |